• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Bioventus LLC

Bioventus names new CEO

March 26, 2020 By Danielle Kirsh

Bioventus this week said it appointed Ken Reali as CEO, effective April 20. Reali will replace Tony Biel who is retiring on April 30. “I am honored to have the opportunity to lead Bioventus,” Reali said in a news release. “The company’s broad product portfolio, global presence and solid growth have it well-positioned to serve […]

Filed Under: Business/Financial News Tagged With: Bioventus LLC

Bioventus launches Osteomatrix+ bone graft

January 17, 2019 By Chris Newmarker

Bioventus announced today that it has started selling Osteomatrix+ – a moldable bone graft substitute intended for a variety of orthopedic and spine bone remodeling applications. Bioventus officials boast that Osteomatrix+ has improved moldability, flexibility and versatility versus its predecessor. “Osteomatrix+ represents the first of several next-generation products that will be added to the Bioventus portfolio […]

Filed Under: Business/Financial News, News Well, Orthopedics Tagged With: Bioventus LLC

Bioventus to deal Pfizer bone protein program to PE shop

July 23, 2018 By Brad Perriello

Bioventus said today that it agreed to sell the bone morphogenetic protein technology it licensed from Pfizer (NYSE:PFE) to private equity shop that specializes in the orthopedics industry for an undisclosed amount. Created in a 2012 spinout worth $367 million from Smith & Nephew (FTSE:SN, NYSE:SNN), Bioventus in 2013 inked a deal with Pfizer to develop a next-generation BMP product. In October 2014 […]

Filed Under: Mergers & Acquisitions, Orthopedics, Regenerative Medicine, Wall Street Beat Tagged With: Bioventus LLC, Viscogliosi Bros.

7 medtech stories we missed this week: Sept. 22, 2017

September 22, 2017 By Danielle Kirsh

From the FDA’s clearance of Covalon’s film-drape to Bioventus launching its study, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. FDA clears Covalon’s MediClear OTC surgical film-drape Covalon announced in a Sept. 21 press release that the FDA has cleared its MediClear PreOp to market in U.S. hospitals, […]

Filed Under: Business/Financial News, Diagnostics, Digital Health, Food & Drug Administration (FDA), Lab Instruments & Supplies, Research & Development, Vascular Tagged With: Bioventus LLC, Contego Medical, Covalon Technologies, Getinge, Guerbet, IBA, ManaMed, Medovex, MedTech

Bioventus wins FDA nod for knee osteoarthritis pain injection

September 5, 2017 By Sarah Faulkner

Bioventus said today that its Durolane single-injection, hyaluronic acid product won FDA approval for the treatment of pain associated with knee osteoarthritis. When a person develops osteoarthritis in their knee, the cartilage breaks down and so does the synovial fluid that provides lubrication to joint tissues. Hyaluronic acid provides cushioning and lubrication to the knee, […]

Filed Under: Food & Drug Administration (FDA), Orthopedics, Pharmaceutical, Regulatory/Compliance Tagged With: Bioventus LLC

Bioventus wins FDA nod for Durolane OA joint lubrication product

September 5, 2017 By Fink Densford

Bioventus said today it won FDA approval for its Durolane injectable product designed for joint lubrication and treating pain associated with knee osteoarthritis. Durolane is a single-injection, hyaluornic acid product designed to lubricate joints to treat pain associated with knee osteoarthritis, Durham, N.C.-based Bioventus said. The company acquired it last December from Galderma for an undisclosed amount. […]

Filed Under: Food & Drug Administration (FDA), Orthopedics, Pain Management, Regulatory/Compliance Tagged With: Bioventus LLC

NuVasive taps new CFO | Personnel Moves – August 15, 2017

August 15, 2017 By Brad Perriello

NuVasive Inc. (NSDQ:NUVA) said today that it tapped Rajesh Asarpota to be its new CFO effective Sept. 1, replacing Quentin Blackford, who jumped ship last month for the top finance spot at Dexcom Inc. (NSDQ:DXCM). San Diego-based NuVasive said Asarpota began his career at GE Healthcare (NYSE:GE)before moving to Life Technologies (NSDQ:LIFE), Questcor Pharmaceuticals and “private equity-backed healthcare […]

Filed Under: Wall Street Beat Tagged With: Bioventus LLC, Endologix, Nuvasive, Personnel Moves

RTI Surgical names new CEO, parts ways with CSO Hartill | Personnel Moves | January 31, 2017

January 31, 2017 By Brad Perriello

RTI Surgical (NSDQ:RTIX) named Camille Farhat as its chief executive officer, effective March 15, 2017. Previously, Farhat served as president & CEO of American Medical Systems, Inc., where he helped facilitate Boston Scientific (NYSE:BSX)’s $1.65 billion acquisition of the men’s and prostate health businesses. He has also held leadership positions with Baxter (NYSE:BAX), Medtronic (NYSE:MDT) and General Electric (NYSE:GE). “Today […]

Filed Under: Business/Financial News Tagged With: Alphatec, Anika Therapeutics Inc., Aurora Spine, Bioventus LLC, Clal Biotech, dla-piper, FDA, Personnel Moves, ReWalk Robotics, RTI Surgical, Senseonics, ZDI Solutions

Bioventus picks up US Durolane rights from Galderma

December 14, 2016 By Fink Densford

Bioventus said today it inked a deal to pick up the U.S. rights for Durolane joint lubrication from Galderma for an undisclosed amount. Galderma’s Durolane is a single-injection, hyaluornic acid product designed to lubricate joints to treat pain associated with knee osteoarthritis, Durham, N.C.-based Bioventus said. “Bringing Durolane to the US is the next step in our […]

Filed Under: Business/Financial News, Orthopedics Tagged With: Bioventus LLC

Study shows no benefit for Exogen bone stim from Bioventus

October 26, 2016 By Fink Densford

A new study, published yesterday in the BMJ, is casting doubts on the healing benefit of Bioventus‘s Exogen ultrasound bone stimulator. The Durham, N.C.-based company’s Exogen is designed to use low-intensity pulsed ultrasound to “help stimulate the body’s natural healing process.” Bioventus touts an 86% healing rate for fractures not healing on their own and 38% […]

Filed Under: Clinical Trials, Orthopedics Tagged With: Bioventus LLC

Bioventus launches Exogen ultrasound bone treatment in Saudi Arabia

September 19, 2016 By Fink Densford

Bioventus said today it launched the Exogen ultrasound bone healing system in Saudi Arabia. The Durham, N.C.-based company’s Exogen is designed to use low-intensity pulsed ultrasound to “help stimulate the body’s natural healing process.” Bioventus touts an 86% healing rate for fractures not healing on their own and 38% faster healing of fresh fractures with […]

Filed Under: Orthopedics, Regenerative Medicine, Ultrasound Tagged With: Bioventus LLC

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS